Tatiana Falcone, MD

Appointed
2007

Education & Fellowships

Fellowship - Cleveland Clinic
Child and Adolescent Psychiatry
Cleveland, OH USA
2007

Residency - Cleveland Clinic
Psychiatry
Cleveland, OH USA
2005

Internship - Cleveland Clinic
Psychiatry
Cleveland, OH USA
2003

Graduate School - Universidad Pontificia Bolvariana
Psychiatry
Medellin,
2001

Medical Education - Universidad Pontificia Bolvariana
MD Medical School
Medellin, Colombia
1996

Additional Training

• Neurophysiology, Epilepsy Course

Certifications

• Psychiatry and Neurology - Child and Adolescent Psychiatry
• Psychiatry and Neurology - Psychiatry

Specialty Interests

anxiety and mood disorders, consultation liaison psychiatry, emergency psychiatry, Epilepsy, psycho-oncology, Psychosis, Schizophrenia, epilepsy and behavior, epilepsy and behavior research interest, psychiatric issues in epilepsy, psychosis

Awards & Honors

• APA public and Community Psychiatry Fellow from 2005–2007
• Member, APA Board of Trustees, 2006
• Child Intervention Prevention Service Fellow in child psychiatry research from 2005–2007
• Member of the APA committee in Hispanic Psychiatrist, 2007–2010
• 40 Most Successful Hispanic leaders by Kaleidoscope Magazine
• APA Transformational Leadership Award 2009–2011

Innovations & Patents

• Dr. Falcone is conducting research in the psychiatric comorbidities of patients with epilepsy and also in a school intervention project to decrease bullying in children with special needs. Also, Dr Falcone has been working on inflammatory markers in youth with psychiatric disorders.

See publications for Tatiana Falcone, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/31/2023, Dr. Falcone has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.